Payne Christopher D's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Aug 18, 2026
- Accession no.
- 0001773751-26-000205
- Filed
- Aug 18, 2026, 5:03 PM ET
- Trade date
- Aug 14, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Payne Christopher DCIK 0001612163 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Class A Common Stock | MOption exerciseAcquired | +545 | –F1 | – | 34,863 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Class A Common Stock | MOption exerciseDisposed | −545 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.
Referenced by the price of 1 transaction in Table I.